GSK is preparing for an overhaul of its research division that will affect hundreds of scientists across the UK, America and Belgium.Under the plans, the pharma
Laith Al is a journalist and writer based in the United Kingdom. He writes for The Times and his work has also appeared in publications such as Jordan News, Psychology Today, BMJ, and The National News. Laith covers a wide range of topics including business, finance, technology, and current affairs.